News

A successful 4th MC and WG meeting, 12-14 February 2020 in Maastricht, The Netherlands

February 21, 2020

Thank you to all speakers, poster presenters and attendees at the 4th EU-CardioRNA COST Action meeting in Maastricht for making it such an interactive, productive and enjoyable event! Congratulations to poster prize winners Fabiana Martino (CZ), Francesco Ruberto (CH) and Teodora Barbalata (RO).  All poster prize winners are invited to give an oral presentation at […]

Two fantastic Research Associate positions at Imperial College London!

February 20, 2020

We are excited to advertise two fantastic opportunities for Research Associates (postdoctoral) at the prestigious National Heart and Lung Institute (NHLI) at Imperial College London. These fixed term research projects at the NHLI, led by Professor Costanza Emanueli, are funded by the British Heart Foundation and will focus on cardiovascular disease. Imperial College London is […]

Dutch RNA Conference

February 19, 2020

The Dutch RNA Network is pleased to invite you to the first Dutch RNA Conference, which will encompass the most exciting areas of RNA research in the Netherlands. The conference will take place in The Hague on 8-9 May 2020, at Leiden University Wijnhaven The Hague campus (see Meeting Information and Registration/Abstract submission). Organizers Wiliam Faller, NKI, Amsterdam. Yael […]

RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy

February 16, 2020

A new paper from the group of our EU-CardioRNA member Maria Carmo-Fonseca on the emerging role of RNA mis-splicing in hypertrophic cardiomyopathy. Published in our IJMS Special Issue “RNAs in Cardiovascular Diseases-CardioRNA EU COST Action”

Call for Applications for Young Talents in Cardiovascular Disease and Neuroscience at Fondazione Pisana per la Scienza, Italy

February 14, 2020

The aim of this Call for Applications is to attract talented researchers to strengthen the FPS research teams in Cardiovascular Disease and Neuroscience and promote innovation in biomedical research. Individual scientists are invited to submit cutting-edge research proposals in synergy with FPS research lines. With these FPS Grants researchers will have the opportunity to pursue […]

A fabulous opportunity for a senior postdoctoral scientist to work on non-coding RNAs in dilated cardiomyopathy at Cadiz University, Spain

February 8, 2020

POSTDOCTORAL SENIOR RESEARCH REQUIRED TO DEVELOP A THREE YEARS PROJECT AT UNIVERSITY OF CADIZ, SPAIN RESEARCH AREAS OF INTEREST Progress towards new therapeutic alternatives in dilated cardiomyopathy through non-coding RNAs Application of transcriptomic in the diagnostic-therapeutic approach of familial dilated cardiomyopathy: an approach to cardiovascular precision medicine LOCATION: University of Cádiz, Spain Lengthens: 3 years […]

New EU-CardioRNA article in the FASEB Journal on a promising circulating circRNA biomarker for CAD

February 2, 2020

The role of circular RNAs (circRNAs) as biomarkers remains poorly characterized. Here, we investigated the performance of the circRNA hsa_circ_0001445 as a biomarker of coronary artery disease (CAD) in a real‐world clinical practice setting.

Chancellor’s Fellowship BHF Centre for Research Excellence at The University of Edinburgh

February 2, 2020

These 5-year Fellowships are intended to support candidates at the start of their independent academic careers in a world-leading environment. Subject to satisfactory review at the end of year 4 as part of the Edinburgh Scientific Academic Training programme to which fellows will enrol  https://www.ed.ac.uk/medicine-vet-medicine/research-support-development-commercialisation/edinburgh-scientific-academic-track  Fellows will then move to a standard University academic open-ended contract. […]

Our new state-of-the-art in-depth review on Regulatory RNAs in Heart Failure published in Circulation is now online!

January 31, 2020

The first official complete EU-CardioRNA publication is now online in Circulation! We address the regulation and functional role of messenger RNAs, microRNAs, long noncoding RNAs, and circular RNAs (ie, regRNAs) in heart failure and debate the utility of regRNAs to diagnose, prognosticate, and treat heart failure As well as discussing the direction for future work […]

EU-CardioRNA Maastricht meeting approaches 12th-14th Feb!

January 27, 2020

As we near the 4th MC and WG EU-CardioRNA meeting in Maastricht, a reminder of the poster preparation details. Maastricht Abstract Submission Instructions.VF There will be poster prizes for the best poster and runners up! The prize will be to receive an oral presentation invitation at the next EU-CardioRNA meeting in Zagreb 7th-11th September 2020! […]

Postdoc opportunity: Cardiac Epigenetics in Experimental Cardiology, KU Leuven, Belgium.

January 26, 2020

An excellent opportunity for a postdoctoral researcher to study epigenetic mechanisms underlying the biology of cardiac remodelling @Experimental Cardiology, KU Leuven. KU Leuven is Belgium’s highest-ranked university as well as one of the oldest and most renowned and innovative research universities in Europe. Apply by 15th February!

New Review: Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection

January 26, 2020

A lovely review from Branislav Kura, Monika Bartekova and other EU-CardioRNA members presenting current understanding of miR-1 and miR-21 in cardiac injury and cardioprotection.

1 2 3 4